BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284-3292. [PMID: 15310771 DOI: 10.1200/jco.2004.10.012] [Cited by in Crossref: 804] [Cited by in F6Publishing: 258] [Article Influence: 44.7] [Reference Citation Analysis]
Number Citing Articles
1 Désolneux G, Mazière C, Vara J, Brouste V, Fonck M, Béchade D, Bécouarn Y, Evrard S. Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only. PLoS One. 2015;10:e0122816. [PMID: 25825874 DOI: 10.1371/journal.pone.0122816] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
2 Francescutti V, Rivera L, Seshadri M, Kim M, Haslinger M, Camoriano M, Attwood K, Kane JM 3rd, Skitzki JJ. The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis. Oncol Rep 2013;30:35-42. [PMID: 23673557 DOI: 10.3892/or.2013.2473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
3 Cioppa T, Vaira M, Bing C, D’Amico S, Bruscino A, Simone MD. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei. World J Gastroenterol 2008; 14(44): 6817-6823 [PMID: 19058307 DOI: 10.3748/wjg.14.6817] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
4 Zhou S, Jiang Y, Liang J, Pei W, Zhou Z. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy. World J Surg Oncol 2021;19:151. [PMID: 34001125 DOI: 10.1186/s12957-021-02255-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Scholer AJ, Oliver JB, Rosado J, Patel JS, Lynch LJ, Spiegler KM, Houck K, Chokshi RJ. Abdominal wall reconstruction after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy. J Surg Res 2018;221:266-74. [PMID: 29229138 DOI: 10.1016/j.jss.2017.08.002] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Adileh M, Mor E, Assaf D, Benvenisti H, Laks S, Ben-Yaacov A, Schtrechman G, Hazzan D, Shacham-Shmueli E, Margalit O, Halpern N, Aderka D, Perelson D, Ariche A, Nissan A. Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Ann Surg Oncol 2021;28:3320-9. [PMID: 32968959 DOI: 10.1245/s10434-020-09165-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Albukhari TAM, Nafady-Hego H, Elgendy H, Abd Elmoneim HM, Nafady A, Alzahrani AM. Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study. Int J Microbiol 2019;2019:6351874. [PMID: 31467552 DOI: 10.1155/2019/6351874] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Aranda E, Abad A, Carrato A, Cervantes A, García-Foncillas J, García Alfonso P, García Carbonero R, Gómez España A, Tabernero JM, Díaz-Rubio E. Treatment recommendations for metastatic colorectal cancer. Clin Transl Oncol 2011;13:162-78. [PMID: 21421461 DOI: 10.1007/s12094-011-0636-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
9 Bhatt A, Kammar P, Mehta S, Damodaran D, Zaveri S, Patel MD, Sinukumar S, Ray M, Seshadri R. Chasing Rainbows? the Possibility of "Cure" in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC-a Retrospective Study by INDEPSO. Indian J Surg Oncol 2019;10:49-56. [PMID: 30886494 DOI: 10.1007/s13193-019-00879-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Spiliotis J, Halkia E, de Bree E. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol 2016;23:e266-75. [PMID: 27330364 DOI: 10.3747/co.23.2831] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
11 Low RN. Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. J Gastrointest Oncol 2016;7:58-71. [PMID: 26941984 DOI: 10.3978/j.issn.2078-6891.2015.115] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
12 Narasimhan V, Flood M, Warrier S, Heriot A. Hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: still a necessity? ANZ J Surg 2020;90:1541-2. [PMID: 32924302 DOI: 10.1111/ans.15794] [Reference Citation Analysis]
13 Amorim BJ, Hong TS, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, Ricciardi R, Clark JW, Ryan DP, Wo JY, Qadan M, Vangel M, Umutlu L, Groshar D, Cañamaques LG, Gervais DA, Mahmood U, Rosen BR, Catalano OA. Clinical impact of PET/MR in treated colorectal cancer patients. Eur J Nucl Med Mol Imaging 2019;46:2260-9. [PMID: 31359108 DOI: 10.1007/s00259-019-04449-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J. Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review. J Surg Oncol 2018;117:245-59. [PMID: 29120491 DOI: 10.1002/jso.24813] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
15 Stiles ZE, Murphy AJ, Anghelescu DL, Brown CL, Davidoff AM, Dickson PV, Glazer ES, Bishop MW, Furman WL, Pappo AS, Lucas JT Jr, Deneve JL. Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2020;27:171-8. [PMID: 30963398 DOI: 10.1245/s10434-019-07339-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
16 Lieto E, Auricchio A, Cardella F, Mabilia A, Basile N, Castellano P, Orditura M, Galizia G. Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations. World J Surg. 2018;42:1154-1160. [PMID: 28929277 DOI: 10.1007/s00268-017-4237-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
17 de Boer NL, Rovers K, Burger JWA, Madsen EVE, Brandt-Kerkhof ARM, Kok NFM, de Wilt JHW, de Reuver PH, Bos A, de Hingh IHJT, Verhoef C. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer. Cancer Med 2020;9:5851-9. [PMID: 32614506 DOI: 10.1002/cam4.3243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Suarez-Weiss KE, Herold A, Gervais D, Palmer E, Amorim B, King JD, Weier L, Shahein T, Bernstine H, Domachevsk L, Cañamaque LG, Umutlu L, Herrmann K, Groshar D, Catalano OA. [Hybrid imaging of the abdomen and pelvis. German version]. Radiologe 2020;60:394-404. [PMID: 32232543 DOI: 10.1007/s00117-020-00660-y] [Reference Citation Analysis]
19 Winder T, Lenz HJ. Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist. 2010;15:836-844. [PMID: 20656916 DOI: 10.1634/theoncologist.2010-0052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
20 Cotte E, Glehen O, Mohamed F, Lamy F, Falandry C, Golfier F, Gilly FN. Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg. 2007;31:1813-1820. [PMID: 17629740 DOI: 10.1007/s00268-007-9146-8] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 7.1] [Reference Citation Analysis]
21 Ito K, Takemura N, Inagaki F, Mihara F, Kurokawa T, Gohda Y, Kiyomatsu T, Yano H, Kokudo N. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases. World J Surg Oncol 2019;17:99. [PMID: 31196097 DOI: 10.1186/s12957-019-1646-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yuh BE, Kwon YS, Shinder BM, Singer EA, Jang TL, Kim S, Stein MN, Mayer T, Ferrari A, Lee N, Parikh RR, Ruel N, Kim WJ, Horie S, Byun SS, Ahlering TE, Kim IY. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer. Prostate Int 2019;7:102-7. [PMID: 31485434 DOI: 10.1016/j.prnil.2018.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Roviello F, Marrelli D, Neri A, Cerretani D, de Manzoni G, Pedrazzani C, Cioppa T, Nastri G, Giorgi G, Pinto E. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033-2040; discussion 2041-2042. [PMID: 17006608 DOI: 10.1007/s00268-006-0498-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Zanon C, Bortolini M, Chiappino I, Simone P, Bruno F, Gaglia P, Airoldi M, Deriu L, Mashiah A. Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer. World J Surg. 2006;30:2025-2032. [PMID: 17058031 DOI: 10.1007/s00268-005-0486-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
25 Spiegelberg J, Neeff H, Holzner P, Runkel M, Fichtner-Feigl S, Glatz T. Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol 2020; 12(8): 903-917 [PMID: 32879667 DOI: 10.4251/wjgo.v12.i8.903] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Jo MH, Suh JW, Yun JS, Namgung H, Park DG. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea. Ann Surg Treat Res 2016;91:157-64. [PMID: 27757392 DOI: 10.4174/astr.2016.91.4.157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sloothaak DA, Mirck B, Punt CJ, Bemelman WA, van der Bilt JD, D'Hoore A, Tanis PJ. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: A systematic review. Br J Cancer. 2014;111:1112-1121. [PMID: 25025964 DOI: 10.1038/bjc.2014.369] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
28 Weber T, Roitman M, Link KH. [Peritoneal carcinomatosis of colorectal origin: results of cytoreductive surgery with peritonectomy and hyperthermic intraoperative chemotherapy]. Chirurg 2013;84:130, 132-9. [PMID: 23247560 DOI: 10.1007/s00104-012-2419-2] [Reference Citation Analysis]
29 Zhang Y, Qin X, Chen W, Liu D, Luo J, Wang H, Wang H. Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta-analysis. Colorectal Dis 2021;23:2846-58. [PMID: 34411399 DOI: 10.1111/codi.15880] [Reference Citation Analysis]
30 Goodman MD, McPartland S, Detelich D, Saif MW. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy.J Gastrointest Oncol. 2016;7:45-57. [PMID: 26941983 DOI: 10.3978/j.issn.2078-6891.2015.111] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
31 Macrì A, Arcoraci V, Belgrano V, Caldana M, Carbonari L, Cioppa T, De Cian F, De Manzoni G, De Simone M, Giardina C, Muffatti F, Orsenigo E, Robella M, Roviello F, Saladino E, Sammartino P, Vaira M. Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy used as treatment of colo-rectal carcinomatosis: a multicentric study. Updates Surg 2020;72:163-70. [PMID: 31729630 DOI: 10.1007/s13304-019-00691-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Sugarbaker PH. Surgical management of carcinomatosis from colorectal cancer. Clin Colon Rectal Surg. 2005;18:190-203. [PMID: 20011302 DOI: 10.1055/s-2005-916280] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
33 Willaert W, Van Der Speeten K, Liberale G, Ceelen W. BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis. BMC Cancer. 2015;15:980. [PMID: 26673788 DOI: 10.1186/s12885-015-1954-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
34 Loughney L, McCaffrey N, Timon CM, Grundy J, McCarren A, Cahill R, Moyna N, Mulsow J. Physical, psychological and nutritional outcomes in a cohort of Irish patients with metastatic peritoneal malignancy scheduled for cytoreductive surgery (CRS) and heated intrapertioneal chemotherapy (HIPEC): An exploratory pilot study. PLoS One 2020;15:e0242816. [PMID: 33296392 DOI: 10.1371/journal.pone.0242816] [Reference Citation Analysis]
35 Vassos N, Förtsch T, Aladashvili A, Hohenberger W, Croner RS. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis. World J Surg Oncol. 2016;14:42. [PMID: 26912149 DOI: 10.1186/s12957-016-0804-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
36 Bastiaenen VP, Klaver CEL, Kok NFM, de Wilt JHW, de Hingh IHJT, Aalbers AGJ, Boerma D, Bremers AJA, Burger JWA, van Duyn EB, Evers P, van Grevenstein WMU, Hemmer PHJ, Madsen EVE, Snaebjornsson P, Tuynman JB, Wiezer MJ, Dijkgraaf MGW, van der Bilt JDW, Tanis PJ. Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial. BMC Cancer 2019;19:254. [PMID: 30898098 DOI: 10.1186/s12885-019-5408-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
37 Hübner M. In search of evidence - PIPAC on the fast lane. Pleura Peritoneum 2018;3:20180119. [PMID: 30911660 DOI: 10.1515/pp-2018-0119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez Á, Rufián-Peña S, Casado-Adam Á, Cosano-Álvarez A, Briceño-Delgado J. Colorectal peritoneal metastases: Optimal management review. World J Gastroenterol 2019; 25(27): 3484-3502 [PMID: 31367152 DOI: 10.3748/wjg.v25.i27.3484] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
39 Chen D, Liu Z, Liu W, Fu M, Jiang W, Xu S, Wang G, Chen F, Lu J, Chen H, Dong X, Li G, Chen G, Zhuo S, Yan J. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun 2021;12:179. [PMID: 33420057 DOI: 10.1038/s41467-020-20429-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
40 Rieser CJ, Hoehn RS, Zenati M, Hall LB, Kang E, Zureikat AH, Lee A, Ongchin M, Holtzman MP, Pingpank JF, Bartlett DL, Choudry MHA. Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a High-Volume Center. Ann Surg Oncol 2021;28:3522-31. [PMID: 33687614 DOI: 10.1245/s10434-021-09627-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, Sarpel U, Labow DM. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18:1024-1031. [PMID: 24577736 DOI: 10.1007/s11605-014-2477-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
42 Topgül K, Çetinkaya MB, Çiğdem Arslan N, Gül MK, Çan M, Gürsel MF, Erdem D, Malazgirt Z. Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details. Ulus Cerrahi Derg 2015;31:138-47. [PMID: 26504417 DOI: 10.5152/UCD.2015.2990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Glockzin G, Gerken M, Lang SA, Klinkhammer-Schalke M, Piso P, Schlitt HJ. Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis. BMC Cancer. 2014;14:807. [PMID: 25369730 DOI: 10.1186/1471-2407-14-807] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
44 Piso P, Arnold D. Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer. Dtsch Arztebl Int. 2011;108:802-808. [PMID: 22190994 DOI: 10.3238/arztebl.2011.0802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
45 de Jong LAW, Elekonawo FMK, Lambert M, de Gooyer JM, Verheul HMW, Burger DM, de Wilt JHW, Chatelut E, Ter Heine R, de Reuver PR, Bremers AJA, van Erp NP. Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study. Cancer Chemother Pharmacol 2020;86:141-50. [PMID: 32594200 DOI: 10.1007/s00280-020-04107-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Yang SY, Kang JH, Kim HS, Han YD, Min BS, Lee KY. Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. J Gastrointest Oncol 2019;10:1251-65. [PMID: 31949946 DOI: 10.21037/jgo.2019.01.36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Li Y, Zhou YF, Liang H, Wang HQ, Hao JH, Zhu ZG, Wan DS, Qin LX, Cui SZ, Ji JF, Xu HM, Wei SZ, Xu HB, Suo T, Yang SJ, Xie CH, Yang XJ, Yang GL. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 2016; 22(30): 6906-6916 [PMID: 27570426 DOI: 10.3748/wjg.v22.i30.6906] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
48 Pelz JO, Chua TC, Esquivel J, Stojadinovic A, Doerfer J, Morris DL, Maeder U, Germer CT, Kerscher AG. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010;10:689. [PMID: 21176206 DOI: 10.1186/1471-2407-10-689] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
49 Ba M, Chen C, Long H, Gong Y, Wu Y, Lin K, Tu Y, Zhang B, Wu W. Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study. Medicine (Baltimore) 2020;99:e21546. [PMID: 32872001 DOI: 10.1097/MD.0000000000021546] [Reference Citation Analysis]
50 Liang L, Wang W, Zhou N, Guo J, Lu Y, Xu H, Zhang S. Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei. World J Surg Oncol 2019;17:192. [PMID: 31718654 DOI: 10.1186/s12957-019-1730-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Poskus E, Strupas K, Gushchin V, Sugarbaker PH. Cytoreductive Surgery and HIPEC in the Baltic States: An International Scientific Workshop with Live Surgery. Viszeralmedizin 2014;30:353-9. [PMID: 26535046 DOI: 10.1159/000368685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
52 Sugarbaker PH. Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review. Indian J Surg Oncol 2019;10:3-23. [PMID: 30948866 DOI: 10.1007/s13193-018-0856-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
53 Aguilera D, Hayes-Jordan A, Anderson P, Woo S, Pearson M, Green H. Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor. Sarcoma 2008;2008:261589. [PMID: 18566684 DOI: 10.1155/2008/261589] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
54 Guo J, Xu A, Sun X, Zhao X, Xia Y, Rao H, Zhang Y, Zhang R, Chen L, Zhang T, Li G, Xu H, Xu D. Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial. JAMA Surg. 2019;154:610-616. [PMID: 30916742 DOI: 10.1001/jamasurg.2019.0153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
55 Burnett A, Lecompte MA, Trabulsi N, Dubé P, Gervais MK, Trilling B, Cloutier AS, Sideris L. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. World J Surg Oncol 2019;17:83. [PMID: 31092250 DOI: 10.1186/s12957-019-1618-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
56 Losa F, Barrios P, Salazar R, Torres-melero J, Benavides M, Massuti T, Ramos I, Aranda E. Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin. Clin Transl Oncol 2014;16:128-40. [DOI: 10.1007/s12094-013-1053-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
57 Senthil M. Assessment of clinical benefit and quality of life in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of peritoneal carcinomatosis. J Gastrointest Oncol 2013;4:3-4. [PMID: 23451328 DOI: 10.3978/j.issn.2078-6891.2013.001] [Reference Citation Analysis]
58 Yano H. Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis from Colorectal Cancer. Clin Colon Rectal Surg 2020;33:372-6. [PMID: 33162842 DOI: 10.1055/s-0040-1714242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Piso P, Dahlke MH, Ghali N, Iesalnieks I, Loss M, Popp F, von Breitenbuch P, Agha A, Lang SA, Kullmann F, Schlitt HJ. Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis 2007;22:1295-300. [DOI: 10.1007/s00384-007-0313-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
60 Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Trials. 2010;11:62. [PMID: 20500867 DOI: 10.1186/1745-6215-11-62] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
61 Le DM, Ahmed S, Ahmed S, Brunet B, Davies J, Doll C, Ferguson M, Ginther N, Gordon V, Hamilton T, Hebbard P, Helewa R, Kim CA, Lee-Ying R, Lim H, Loree JM, McGhie JP, Mulder K, Park J, Renouf D, Wong RPW, Zaidi A, Asif T. Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018. Curr Oncol 2019;26:e773-84. [PMID: 31896948 DOI: 10.3747/co.26.5517] [Reference Citation Analysis]
62 Ung L, Chua TC, David L M. Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy. J Cancer Res Clin Oncol 2013;139:1899-908. [PMID: 24052322 DOI: 10.1007/s00432-013-1507-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
63 Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines (Basel) 2018;6:E54. [PMID: 30103457 DOI: 10.3390/vaccines6030054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
64 Liu K, Wang ZQ, Wang SJ, Liu P, Qin YH, Ma Y, Li XC, Huo ZJ. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation. Int J Nanomedicine 2015;10:6445-54. [PMID: 26491300 DOI: 10.2147/IJN.S89476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
65 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Rosa F, Galiandro F, Ricci R, Di Miceli D, Quero G, Fiorillo C, Cina C, Alfieri S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes. Langenbecks Arch Surg 2021. [PMID: 34661754 DOI: 10.1007/s00423-021-02353-z] [Reference Citation Analysis]
67 Li XB, Peng KW, Ji ZH, Yu Y, Liu G, Li Y. Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program. Clin Appl Thromb Hemost 2019;25:1076029619890415. [PMID: 31775523 DOI: 10.1177/1076029619890415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Ramirez Plaza CP, Cobo Dols MA, Gomez Portilla A, de la Fuente Perucho A. Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcino-matosis of colorectal origin. Clin Transl Oncol. 2005;7:421-431. [PMID: 16373050 DOI: 10.1007/BF02716592] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Kuncewitch M, Levine EA, Shen P, Votanopoulos KI. The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Tumors and Colorectal Adenocarcinomas. Clin Colon Rectal Surg 2018;31:288-94. [PMID: 30186050 DOI: 10.1055/s-0038-1642052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Vásquez Jiménez W, González Bayón L, García-Sabrido JL, González Moreno S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease. Clin Transl Oncol 2010;12:794-804. [PMID: 21156410 DOI: 10.1007/s12094-010-0601-x] [Reference Citation Analysis]
71 Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg 2009; 1(1): 38-48 [PMID: 21160794 DOI: 10.4240/wjgs.v1.i1.38] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
72 Kobayashi H, Kotake K, Sugihara K. Impact of R0 resection for synchronous peritoneal metastasis from colorectal cancer: A propensity score-matched analysis of a multi-institutional database. Ann Gastroenterol Surg 2021;5:221-7. [PMID: 33860142 DOI: 10.1002/ags3.12405] [Reference Citation Analysis]
73 Kwakman R, de Cuba EM, de Winter JP, de Hingh IH, Delis-van Diemen PM, Tijssen M, Rooimans MA, Krijgsman O, Carvalho B, Peters GJ. Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival. Br J Cancer. 2015;112:851-856. [PMID: 25668003 DOI: 10.1038/bjc.2015.18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
74 Morano WF, Aggarwal A, Love P, Richard SD, Esquivel J, Bowne WB. Intraperitoneal immunotherapy: historical perspectives and modern therapy. Cancer Gene Ther. 2016;23:373-381. [PMID: 27834358 DOI: 10.1038/cgt.2016.49] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
75 Glockzin G, Ghali N, Lang SA, Agha A, Schlitt HJ, Piso P. Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy. Chirurg. 2007;78:1100, 1102-1106, 1108-1110. [PMID: 17992490 DOI: 10.1007/s00104-007-1419-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
76 Kapoor S, Bassily-Marcus A, Alba Yunen R, Tabrizian P, Semoin S, Blankush J, Labow D, Oropello J, Manasia A, Kohli-Seth R. Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. World J Crit Care Med 2017; 6(2): 116-123 [PMID: 28529913 DOI: 10.5492/wjccm.v6.i2.116] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Tan GHC, Shannon NB, Chia CS, Lee LS, Soo KC, Teo MCC. The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Asian J Urol 2018;5:194-8. [PMID: 29988907 DOI: 10.1016/j.ajur.2017.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
78 Glockzin G, Rochon J, Arnold D, Lang SA, Klebl F, Zeman F, Koller M, Schlitt HJ, Piso P. A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial. BMC Cancer. 2013;13:67. [PMID: 23391248 DOI: 10.1186/1471-2407-13-67] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
79 Mogal H, Chouliaras K, Levine EA, Shen P, Votanopoulos KI. Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Review of indications and outcomes. J Gastrointest Oncol. 2016;7:129-142. [PMID: 26941991 DOI: 10.3978/j.issn.2078-6891.2015.131] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
80 Liu JB, Schuitevoerder D, Vining CC, Berger Y, Turaga KK, Eng OS. Benchmarking Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement. Ann Surg Oncol 2020;27:5039-46. [PMID: 32729047 DOI: 10.1245/s10434-020-08815-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Van der Speeten K, Stuart OA, Sugarbaker PH. Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy. Curr Drug Discov Technol. 2009;6:72-81. [PMID: 19275544 DOI: 10.2174/157016309787581084] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
82 Yonemura Y, Elnemr A, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y. Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection. Gastroenterol Res Pract. 2012;2012:521487. [PMID: 22666235 DOI: 10.1155/2012/521487] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
83 Bacalbasa N, Balescu I, Cretoiu D, Halmaciu I, Dimitriu M, Socea B, Diaconu C, Iliescu L, Savu C, Savu C, Filipescu A, Stoica C, Stiru O. Determination of whether HIPEC is beneficial in patients with synchronous peritoneal and liver metastases from colorectal cancer (Review). Exp Ther Med 2021;22:1267. [PMID: 34594404 DOI: 10.3892/etm.2021.10702] [Reference Citation Analysis]
84 Pamela K, Matthias Z, Reinhold KR, Julia P, Peter M, Alexander P, Dietmar Ö. Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria. J Gastrointest Surg 2018;22:884-93. [PMID: 29363016 DOI: 10.1007/s11605-017-3661-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
85 Robella M, Vaira M, De Simone M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol. 2016;14:128. [PMID: 27125996 DOI: 10.1186/s12957-016-0892-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
86 Di Giorgio A, Santullo F, Attalla El Halabieh M, Lodoli C, Abatini C, Calegari MA, Martini M, Rotolo S, Pacelli F. Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer. J Gastrointest Surg 2021. [PMID: 34244953 DOI: 10.1007/s11605-021-05073-3] [Reference Citation Analysis]
87 Vicente D, Avital I, Stojadinovic A. Role of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literature. World J Surg Oncol 2015;13:2. [PMID: 26264074 DOI: 10.1186/1477-7819-13-2] [Reference Citation Analysis]
88 Leimkühler M, Hentzen JEKR, Hemmer PHJ, Been LB, van Ginkel RJ, Kruijff S, van Leeuwen BL, de Bock GH. Systematic Review of Factors Affecting Quality of Life After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2020;27:3973-83. [PMID: 32335752 DOI: 10.1245/s10434-020-08379-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
89 Huang CQ, Feng JP, Yang XJ, Li Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: A case-control study from a Chinese center. J Surg Oncol. 2014;109:730-739. [PMID: 24374987 DOI: 10.1002/jso.23545] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
90 Van der Speeten K, Govaerts K, Stuart OA, Sugarbaker PH. Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients. Gastroenterol Res Pract 2012;2012:378064. [PMID: 22778722 DOI: 10.1155/2012/378064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
91 Li S, Zhang YL, Sun JY, Hua YW, Wu PH. Safe temperature range for intraoperative and early postoperative continuous hyperthermic intraperitoneal perfusion in a swine model of experimental distal gastrectomy with Billroth II reconstruction. J Transl Med 2013;11:181. [PMID: 23895276 DOI: 10.1186/1479-5876-11-181] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Martin D, Grass F, Deo SVS, Ashwin KR, Maheshwari A, Hübner M, Somashekhar SP. Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM). J Gastrointest Cancer 2021;52:1061-6. [PMID: 33073299 DOI: 10.1007/s12029-020-00538-1] [Reference Citation Analysis]
93 Sipok A, Sardi A, Nieroda C, King MC, Sittig M, Gushchin V. Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent. Int J Surg Oncol 2018;2018:1920276. [PMID: 30643644 DOI: 10.1155/2018/1920276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
94 Sun T, Li K, Xu G, Zhu K, Wang Q, Dang C, Yuan D. Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis. World J Surg Oncol 2021;19:200. [PMID: 34229721 DOI: 10.1186/s12957-021-02320-4] [Reference Citation Analysis]
95 Sugarbaker PH. Are there curative options to peritoneal carcinomatosis? Ann Surg 2005;242:748-50; author reply 750-1. [PMID: 16244553 DOI: 10.1097/00000658-200511000-00023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
96 Dubé P, Sideris L, Law C, Mack L, Haase E, Giacomantonio C, Govindarajan A, Krzyzanowska MK, Major P, McConnell Y, Temple W, Younan R, McCart JA. Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Curr Oncol 2015;22:e100-12. [PMID: 25908915 DOI: 10.3747/co.22.2058] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
97 Lin EK, Hsieh MC, Chen CH, Lu YJ, Wu SY. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis. Medicine (Baltimore). 2016;95:e5522. [PMID: 28033247 DOI: 10.1097/md.0000000000005522] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
98 Duraj FF, Cashin PH. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study. J Gastrointest Oncol 2013;4:388-96. [PMID: 24294511 DOI: 10.3978/j.issn.2078-6891.2013.026] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
99 Johnston FM, Kneuertz PJ, Pawlik TM. Resection of non-hepatic colorectal cancer metastasis. J Gastrointest Oncol 2012;3:59-68. [PMID: 22811870 DOI: 10.3978/j.issn.2078-6891.2012.007] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
100 Kilian M, Hammerich R, Langelotz C, Raue W, Tsilimparis N, Rau B, Hartmann J. [Hyperthermic intraperitoneal chemotherapy in the German DRG system. Analysis of case cost calculations of a maximum care university]. Chirurg 2010;81:1005-12. [PMID: 20552152 DOI: 10.1007/s00104-010-1927-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
101 Aarts F, Hendriks T, Boerman OC, Koppe MJ, Oyen WJ, Bleichrodt RP. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol 2007;14:3274-82. [PMID: 17653591 DOI: 10.1245/s10434-007-9509-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
102 Fujishima Y, Goi T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A. MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer. Int J Oncol 2012;40:960-4. [PMID: 22266876 DOI: 10.3892/ijo.2012.1334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
103 Spiliotis J, Kalles V, Kyriazanos I, Terra A, Prodromidou A, Raptis A, Kopanakis N, Christopoulou A. CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival. Pleura Peritoneum 2019;4:20190018. [PMID: 31799372 DOI: 10.1515/pp-2019-0018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
104 Barral M, El-Sanharawi I, Dohan A, Sebuhyan M, Guedon A, Delarue A, Boutigny A, Mohamedi N, Magnan B, Kemel S, Ketfi C, Kubis N, Bisdorff-Bresson A, Pocard M, Bonnin P. Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor Diseases. Front Physiol 2021;12:693052. [PMID: 34413786 DOI: 10.3389/fphys.2021.693052] [Reference Citation Analysis]
105 Roviello F, Marrelli D, Neri A, Cerretani D, de Manzoni G, Pedrazzani C, Cioppa T, Nastri G, Giorgi G, Pinto E. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033-2040. [PMID: 17006608 DOI: 10.1007/s00268-006-0038-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
106 Zhu Y, Hanna N, Boutros C, Alexander HR Jr. Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases. J Gastrointest Oncol 2013;4:62-71. [PMID: 23450068 DOI: 10.3978/j.issn.2078-6891.2012.053] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
107 Bhatt A, Goéré D. Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer. Indian J Surg Oncol 2016;7:177-87. [PMID: 27065708 DOI: 10.1007/s13193-016-0499-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
108 Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597-603. [PMID: 17414609 DOI: 10.1097/01.sla.0000255561.87771.11] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
109 Pameijer CR. HIPEC Trials and the US: A Review and Call to Action. Ann Surg Oncol 2021. [PMID: 34599434 DOI: 10.1245/s10434-021-10769-6] [Reference Citation Analysis]
110 Sun CF, Tan ZH, Shen C, Mao XY, Ge CC, Gao Y, Hu CH. Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index. Cancer Biother Radiopharm 2020. [PMID: 32833546 DOI: 10.1089/cbr.2020.3733] [Reference Citation Analysis]
111 Laks S, Schtrechman G, Adileh M, Ben-Yaacov A, Purim O, Ivanov V, Aderka D, Shacham-Shmueli E, Halpern N, Goren S, Perelson D, Nissan A. Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious. Ann Surg Oncol 2021;28:5330-8. [PMID: 33591479 DOI: 10.1245/s10434-021-09684-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
112 Sugarbaker PH, Van der Speeten K, Stuart OA. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol 2010; 2(1): 19-30 [PMID: 21160813 DOI: 10.4251/wjgo.v2.i1.19] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
113 Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, Beltramo JL, Drogoul C, Simonet M, Benoit L, Rat P, Chauffert B. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 2006;244:106-12. [PMID: 16794395 DOI: 10.1097/01.sla.0000218089.61635.5f] [Cited by in Crossref: 118] [Cited by in F6Publishing: 104] [Article Influence: 7.4] [Reference Citation Analysis]
114 Votanopoulos KI, Swett K, Blackham AU, Ihemelandu C, Shen P, Stewart JH, Levine EA. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer. Ann Surg Oncol 2013;20:1088-92. [PMID: 23456381 DOI: 10.1245/s10434-012-2787-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
115 Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, Ichinose M, Miura M, Li Y. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol 2010; 2(2): 85-97 [PMID: 21160926 DOI: 10.4251/wjgo.v2.i2.85] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
116 Nassour I, Polanco PM. Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion. Curr Colorectal Cancer Rep 2017;13:144-53. [PMID: 28890671 DOI: 10.1007/s11888-017-0361-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
117 Hayes-Jordan A, LaQuaglia MP, Modak S. Management of desmoplastic small round cell tumor. Semin Pediatr Surg 2016;25:299-304. [PMID: 27955733 DOI: 10.1053/j.sempedsurg.2016.09.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
118 Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg. 2006;243:212-222. [PMID: 16432354 DOI: 10.1097/01.sla.0000197702.46394.16] [Cited by in Crossref: 346] [Cited by in F6Publishing: 306] [Article Influence: 21.6] [Reference Citation Analysis]
119 Huang CQ, Min Y, Wang SY, Yang XJ, Liu Y, Xiong B, Yonemura Y, Li Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget 2017;8:55657-83. [PMID: 28903452 DOI: 10.18632/oncotarget.17497] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 12.2] [Reference Citation Analysis]
120 Emoto S, Sunami E, Yamaguchi H, Ishihara S, Kitayama J, Watanabe T. Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer. Surg Today. 2014;44:2209-2220. [PMID: 24482110 DOI: 10.1007/s00595-014-0848-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
121 Suarez-Weiss KE, Herold A, Gervais D, Palmer E, Amorim B, King JD, Weier L, Shahein T, Bernstine H, Domachevsk L, Cañamaque LG, Herrmann K, Umutlu L, Groshar D, Catalano OA. Hybrid imaging of the abdomen and pelvis.Radiologe. 2020;60:80-89. [PMID: 32424463 DOI: 10.1007/s00117-020-00661-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
122 Cascales-Campos PA, López-López V, Torres-Melero J, Arjona A, Muñoz-Casares FC, Barrios P, Morales R, Pereira F, Bretcha-Boix P, González-Bayón L, González-Moreno S, Gil J. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP). Clin Transl Oncol 2020;22:130-6. [PMID: 31049819 DOI: 10.1007/s12094-019-02124-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Seshadri RA, Hemanth Raj E. Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies. Indian J Surg Oncol 2016;7:230-5. [PMID: 27065714 DOI: 10.1007/s13193-015-0486-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
124 Blackham AU, Russell GB, Stewart JH, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21:2667-2674. [PMID: 24615177 DOI: 10.1245/s10434-014-3563-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
125 Stewart CL, Warner S, Ito K, Raoof M, Wu GX, Kessler J, Kim JY, Fong Y. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg 2018;55:330-79. [PMID: 30526930 DOI: 10.1067/j.cpsurg.2018.08.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
126 Eveno C, Mojica K, Ady JW, Thorek DL, Longo V, Belin LJ, Gholami S, Johnsen C, Zanzonico P, Chen N, Yu T, Szalay AA, Fong Y. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis. Surgery 2015;157:331-7. [PMID: 25616946 DOI: 10.1016/j.surg.2014.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
127 Guend H, Patel S, Nash GM. Abdominal metastases from colorectal cancer: intraperitoneal therapy. J Gastrointest Oncol 2015;6:693-8. [PMID: 26697203 DOI: 10.3978/j.issn.2078-6891.2015.078] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
128 Huang CQ, Yang XJ, Yu Y, Wu HT, Liu Y, Yonemura Y, Li Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center. PLoS One. 2014;9:e108509. [PMID: 25259574 DOI: 10.1371/journal.pone.0108509] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
129 Teo MCC, Tan GHC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care? Singapore Med J 2018;59:116-20. [PMID: 29568842 DOI: 10.11622/smedj.2018025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Roh SJ, Park SC, Choi J, Lee JS, Lee DW, Hong CW, Han KS, Park HC, Sohn DK, Oh JH. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis. Ann Coloproctol 2020;36:22-9. [PMID: 32146785 DOI: 10.3393/ac.2019.04.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
131 García KM, Flores KM, Ruiz A, González FL, Rodríguez ÁM. Pseudomyxoma Peritonei: Case Report and Literature Review. J Gastrointest Cancer 2019;50:1037-42. [PMID: 30618002 DOI: 10.1007/s12029-018-00192-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Li S, Li L, Tan B, Wang J, Xue S. The benefits of surgery plus extensive intraoperative peritoneal lavage (EIPL) for patients with gastric cancer compared with surgery alone: a systematic review and meta-analysis. Updates Surg 2021. [PMID: 34170498 DOI: 10.1007/s13304-021-01120-5] [Reference Citation Analysis]
133 Sgarbura O, Samalin E, Carrere S, Mazard T, de Forges H, Alline M, Pissas MH, Portales F, Ychou M, Quenet F. Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: A pilot study. Pleura Peritoneum. 2016;1:209-215. [PMID: 30911625 DOI: 10.1515/pp-2016-0018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
134 al-Shammaa HAH, Li Y, Yonemura Y. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol 2008; 14(8): 1159-1166 [PMID: 18300340 DOI: 10.3748/wjg.14.1159] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
135 Rampone B, Schiavone B, Martino A, Confuorto G. Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer. World J Gastroenterol 2010; 16(11): 1299-1302 [PMID: 20238394 DOI: 10.3748/wjg.v16.i11.1299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
136 Shariff F, Bischof D, Govindarajan A, Prince R, Burkes R, Haase E, Mack L, Temple W, Hebbard P, Boulanger-Gobeil C, Giacomantonio C, Brind'Amour A, Sidéris L, Dubé P, Hamilton T, MacNeill A, Bouchard-Fortier A, Younan R, McCart A. Evidence-Based Strategies for the Treatment of Peritoneal Malignancies during Health Care Resource Restriction: The COVID-19 Pandemic. Curr Oncol 2020;28:40-51. [PMID: 33704173 DOI: 10.3390/curroncol28010006] [Reference Citation Analysis]
137 Hultman B, Mahteme H, Sundbom M, Ljungman M, Larsson R, Nygren P. Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy. J Exp Clin Cancer Res. 2014;33:110. [PMID: 25528067 DOI: 10.1186/s13046-014-0110-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
138 Ramírez-Plaza CP, Moreno-Ruiz FJ, Pérez-Daga JA. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature. World J Surg Oncol 2015;13:233. [PMID: 26231227 DOI: 10.1186/s12957-015-0654-y] [Reference Citation Analysis]
139 Rentsch M, Schiergens T, Khandoga A, Werner J. Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives. Visc Med 2016;32:184-91. [PMID: 27493946 DOI: 10.1159/000446490] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
140 Khosrawipour V, Giger-Pabst U, Khosrawipour T, Pour YH, Diaz-Carballo D, Förster E, Böse-Ribeiro H, Adamietz IA, Zieren J, Fakhrian K. Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model. J Cancer 2016;7:910-4. [PMID: 27313780 DOI: 10.7150/jca.14714] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
141 Shaligram A. Management of peritoneal surface malignancies in laparoscopic era: a concise review. Int J Surg Oncol (N Y) 2016;1:e05. [PMID: 29177208 DOI: 10.1097/IJ9.0000000000000005] [Reference Citation Analysis]
142 Chouillard E, Ata T, De Jonghe B, Maggiori L, Helmy N, Coscas Y, Outin H. Staged laparoscopic adjuvant intraperitoneal chemohyperthermia after complete resection for locally advanced colorectal or gastric cancer: a preliminary experience. Surg Endosc 2009;23:363-9. [PMID: 18461388 DOI: 10.1007/s00464-008-9946-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
143 Ellebæk SB, Graversen M, Detlefsen S, Lundell L, Fristrup CW, Pfeiffer P, Mortensen MB. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum 2020;5:20200109. [PMID: 32566727 DOI: 10.1515/pp-2020-0109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
144 García-Fadrique A, Estevan Estevan R, Sabater Ortí L. Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2021. [PMID: 34435297 DOI: 10.1245/s10434-021-10642-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Rovers KP, Bakkers C, van Erning FN, Burger JWA, Nienhuijs SW, Simkens GAAM, Creemers GM, Hemmer PHJ, Punt CJA, Lemmens VEPP, Tanis PJ, de Hingh IHJT. Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases. JAMA Oncol 2020;6:e202701. [PMID: 32672798 DOI: 10.1001/jamaoncol.2020.2701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
146 Esquivel J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection. J Gastrointest Oncol 2016;7:72-8. [PMID: 26941985 DOI: 10.3978/j.issn.2078-6891.2015.114] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
147 Hentzen JEKR, van der Plas WY, Constansia RDN, Been LB, Hoogwater FJH, van Ginkel RJ, van Dam GM, Hemmer PHJ, Kruijff S. Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. BJS Open 2019;3:812-21. [PMID: 31832588 DOI: 10.1002/bjs5.50193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
148 Yu HH, Yonemura Y, Hsieh MC, Mizumoto A, Wakama S, Lu CY. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center. Cancer Manag Res 2017;9:513-23. [PMID: 29089784 DOI: 10.2147/CMAR.S147227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
149 Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM. Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. J Clin Med 2020;9:E748. [PMID: 32164300 DOI: 10.3390/jcm9030748] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
150 Kasumi E, Sato N. A ketogenic diet improves the prognosis in a mouse model of peritoneal dissemination without tumor regression. J Clin Biochem Nutr 2019;64:201-8. [PMID: 31138953 DOI: 10.3164/jcbn.18-103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
151 Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open 2019;3:585-94. [PMID: 31592510 DOI: 10.1002/bjs5.50179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
152 Uemura M, Qiao W, Fournier K, Morris J, Mansfield P, Eng C, Royal RE, Wolff RA, Raghav K, Mann GN, Overman MJ. Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery. BMC Cancer 2017;17:331. [PMID: 28506255 DOI: 10.1186/s12885-017-3327-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
153 Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677-3683. [PMID: 19470929 DOI: 10.1200/jco.2008.20.5278] [Cited by in Crossref: 819] [Cited by in F6Publishing: 381] [Article Influence: 63.0] [Reference Citation Analysis]
154 Cui HG, Cao XF. Surgery-predominant combined treatment for colorectal cancer. Shijie Huaren Xiaohua Zazhi 2008; 16(16): 1774-1780 [DOI: 10.11569/wcjd.v16.i16.1774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Hartmann J, Kilian M, Atanassov V, Braumann C, Ordemann J, Jacobi CA. First surgical tumour reduction of peritoneal surface malignancy in a rat's model. Clin Exp Metastasis 2008;25:445-9. [PMID: 18301991 DOI: 10.1007/s10585-008-9150-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
156 Sammartino P, Sibio S, Biacchi D, Cardi M, Mingazzini P, Rosati MS, Cornali T, Sollazzo B, Atta JM, Di Giorgio A. Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. Int J Colorectal Dis. 2014;29:1081-1089. [PMID: 24980687 DOI: 10.1007/s00384-014-1929-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
157 Konstantinidis IT, Levine EA, Chouliaras K, Russell G, Shen P, Votanopoulos KI. Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2017;116:741-5. [PMID: 28608388 DOI: 10.1002/jso.24703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
158 Frühling P, Ghanipour L, Dranichnikov P, Enblad M, Birgisson H, Cashin PH. Oxaliplatin-based hyperthermic intraperitoneal chemotherapy with single drug versus multiple drug treatment for colorectal cancer with peritoneal metastases: an observational cohort study. J Gastrointest Oncol 2021;12:516-26. [PMID: 34012645 DOI: 10.21037/jgo-20-494] [Reference Citation Analysis]
159 Leimkühler M, Hemmer PHJ, Reyners AKL, de Groot DJA, van Ginkel RJ, Been LB, de Bock GH, van Leeuwen BL. Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study. World J Surg Oncol 2019;17:14. [PMID: 30635070 DOI: 10.1186/s12957-018-1554-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
160 Miyake H, Murono K, Nagata H, Nozawa H, Kawai K, Hata K, Tanaka T, Nishikawa T, Shuno Y, Sasaki K, Ishihara S. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer. Int J Colorectal Dis 2019;34:801-9. [PMID: 30739186 DOI: 10.1007/s00384-019-03259-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
161 Hentzen JEKR, Rovers KP, Kuipers H, van der Plas WY, Been LB, Hoogwater FJH, van Ginkel RJ, Hemmer PHJ, van Dam GM, de Hingh IHJT, Kruijff S. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study. Ann Surg Oncol 2019;26:2210-21. [PMID: 30877495 DOI: 10.1245/s10434-019-07294-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
162 Benoit L, Cheynel N, Ortega-Deballon P, Giacomo GD, Chauffert B, Rat P. Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs. Ann Surg Oncol 2008;15:542-6. [PMID: 17929098 DOI: 10.1245/s10434-007-9635-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
163 Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA. Management of peritoneal carcinomatosis from colorectal cancer. Semin Oncol 2011;38:568-75. [PMID: 21810516 DOI: 10.1053/j.seminoncol.2011.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
164 Mohamed F, Cecil T, Moran B, Sugarbaker P. A new standard of care for the management of peritoneal surface malignancy. Curr Oncol. 2011;18:e84-e96. [PMID: 21505593 DOI: 10.3747/co.v18i2.663] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
165 Konstantinidis IT, Young C, Tsikitis VL, Lee E, Jie T, Ong ES. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience. World J Gastrointest Surg 2012; 4(6): 135-140 [PMID: 22816027 DOI: 10.4240/wjgs.v4.i6.135] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
166 Brücher B, Stojadinovic A, Bilchik A, Protic M, Daumer M, Nissan A, Itzhak A. Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomy. J Cancer. 2013;4:262-269. [PMID: 23459716 DOI: 10.7150/jca.5831] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
167 Pelz JO, Doerfer J, Hohenberger W, Meyer T. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis. BMC Cancer 2005;5:56. [PMID: 15924622 DOI: 10.1186/1471-2407-5-56] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
168 Tan GH, Teo MC, Chen W, Lee SY, Ng DW, Tham CK, Soo KC. Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases. J Gastrointest Cancer. 2013;44:170-176. [PMID: 23138597 DOI: 10.1007/s12029-012-9452-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
169 Links M. Analogies between reading of medical and religious texts. BMJ 2006;333:1068-70. [PMID: 17110727 DOI: 10.1136/bmj.38966.487350.68] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
170 Macrì A, Saladino E, Bartolo V, Adamo V, Altavilla G, Mondello E, Condemi G, Sinardi A, Famulari C. Peritoneal carcinomatosis of colorectal origin. World J Gastrointest Oncol 2010; 2(2): 98-101 [PMID: 21160927 DOI: 10.4251/wjgo.v2.i2.98] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
171 Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;2:3. [PMID: 15701175 DOI: 10.1186/1477-7800-2-3] [Cited by in Crossref: 165] [Cited by in F6Publishing: 149] [Article Influence: 9.7] [Reference Citation Analysis]
172 Kamada Y, Hida K, Ishibashi H, Sako S, Mizumoto A, Ichinose M, Padmanabhan N, Yoshida S, Yonemura Y. Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study. World J Surg Oncol 2021;19:31. [PMID: 33509224 DOI: 10.1186/s12957-021-02145-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
173 Passot G, Dupré A, Rivoire M, Mohamed F, Bakrin N, Glehen O. Intraperitoneal bevacizumab combined with cytoreductive surgery: a pre-clinical study of tolerance and pharmacokinetics in an animal model. Clin Transl Oncol. 2012;14:931-936. [PMID: 22855172 DOI: 10.1007/s12094-012-0888-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
174 Canbay E, Torun BC, Torun ES, Yonemura Y. Evolution of management in peritoneal surface malignancies. Ulus Cerrahi Derg 2016;32:203-7. [PMID: 27528813 DOI: 10.5152/UCD.2016.3375] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
175 Cardi M, Sibio S, Di Marzo F, Lefoche F, d'Agostino C, Fonsi GB, La Torre G, Carbonari L, Sammartino P. Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center. Gastroenterol Res Pract 2019;2019:2824073. [PMID: 31191642 DOI: 10.1155/2019/2824073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Coccolini F, Gheza F, Lotti M, Virzì S, Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L, Catena F. Peritoneal carcinomatosis. World J Gastroenterol 2013; 19(41): 6979-6994 [PMID: 24222942 DOI: 10.3748/wjg.v19.i41.6979] [Cited by in CrossRef: 135] [Cited by in F6Publishing: 116] [Article Influence: 15.0] [Reference Citation Analysis]
177 Prabhu A, Brandl A, Wakama S, Sako S, Ishibashi H, Mizumoto A, Takao N, Ichinose M, Motoi S, Liu Y, Yonemura Y. Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study. BJS Open 2021;5:zraa075. [PMID: 33839755 DOI: 10.1093/bjsopen/zraa075] [Reference Citation Analysis]
178 Guerrero W, Munene G, Dickson PV, Stiles ZE, Mays J, Davidoff AM, Glazer ES, Shibata D, Deneve JL. Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis. J Gastrointest Oncol 2018;9:664-73. [PMID: 30151262 DOI: 10.21037/jgo.2018.04.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
179 Mirnezami R, Moran BJ, Harvey K, Cecil T, Chandrakumaran K, Carr N, Mohamed F, Mirnezami AH. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases. World J Gastroenterol 2014; 20(38): 14018-14032 [PMID: 25320542 DOI: 10.3748/wjg.v20.i38.14018] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
180 Solaini L, D'Acapito F, Passardi A, Framarini M, Tauceri F, Di Pietrantonio D, Frassineti GL, Casadei Gardini A, Cucchetti A, Cavaliere D, Ercolani G. Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study. World J Surg Oncol 2019;17:58. [PMID: 30917826 DOI: 10.1186/s12957-019-1602-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
181 Dehal A, Smith JJ, Nash GM. Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol. 2016;7:143-157. [PMID: 26941992 DOI: 10.3978/j.issn.2078-6891.2015.112] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
182 Koumpa FS, Xylas D, Konopka M, Galea D, Veselkov K, Antoniou A, Mehta A, Mirnezami R. Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research. Gastroenterol Res Pract. 2019;2019:5180895. [PMID: 31065262 DOI: 10.1155/2019/5180895] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
183 Benizri EI, Bernard JL, Rahili A, Benchimol D, Bereder JM. Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2012;10:56. [PMID: 22494563 DOI: 10.1186/1477-7819-10-56] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
184 Jeong SJ, Yoon YS, Lee JB, Lee JL, Kim CW, Park IJ, Lim SB, Yu CS, Kim JC. Palliative surgery for colorectal cancer with peritoneal metastasis: a propensity-score matching analysis. Surg Today 2017;47:159-65. [PMID: 27549772 DOI: 10.1007/s00595-016-1402-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
185 Spring BQ, Abu-Yousif AO, Palanisami A, Rizvi I, Zheng X, Mai Z, Anbil S, Sears RB, Mensah LB, Goldschmidt R, Erdem SS, Oliva E, Hasan T. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc Natl Acad Sci U S A 2014;111:E933-42. [PMID: 24572574 DOI: 10.1073/pnas.1319493111] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 8.4] [Reference Citation Analysis]
186 Sayyed R; PSM Pakistan Working Group. Management of Peritoneal Surface Malignancies in Pakistan. Indian J Surg Oncol 2019;10:37-40. [PMID: 30886492 DOI: 10.1007/s13193-019-00880-2] [Reference Citation Analysis]
187 Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA. Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol 2013;20:3497-503. [PMID: 23780382 DOI: 10.1245/s10434-013-3053-z] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
188 Kelly ME, Murphy E, Keyes AM, Khan MF, Bolger JC, Grundy J, Conneely J, MacHale J, McCaffrey J, Cahill R, Moran B, Shields C, Mulsow J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: outcomes from a national centre in the current era. Ir J Med Sci 2021. [PMID: 33420573 DOI: 10.1007/s11845-021-02506-5] [Reference Citation Analysis]
189 Valle SJ, Alzahrani NA, Liauw W, Sugarbaker PH, Bhatt A, Morris DL. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy. Indian J Surg Oncol 2016;7:152-9. [PMID: 27065705 DOI: 10.1007/s13193-016-0498-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
190 Macrì A, Fortugno A, Saladino E. Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia. World J Gastrointest Oncol 2011; 3(12): 169-174 [PMID: 22224171 DOI: 10.4251/wjgo.v3.i12.169] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
191 Chua TC, Yan TD, Ng KM, Zhao J, Morris DL. Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis. World J Surg. 2009;33:1488-1494. [PMID: 19412567 DOI: 10.1007/s00268-009-0059-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
192 Yan TD, Stuart OA, Yoo D, Sugarbaker PH. Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy. J Transl Med 2006;4:17. [PMID: 16606461 DOI: 10.1186/1479-5876-4-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
193 Carpinteri S, Sampurno S, Bernardi MP, Germann M, Malaterre J, Heriot A, Chambers BA, Mutsaers SE, Lynch AC, Ramsay RG. Peritoneal Tumorigenesis and Inflammation are Ameliorated by Humidified-Warm Carbon Dioxide Insufflation in the Mouse. Ann Surg Oncol 2015;22 Suppl 3:S1540-7. [PMID: 25794828 DOI: 10.1245/s10434-015-4508-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
194 Kobayashi H, Kotake K, Funahashi K, Hase K, Hirata K, Iiai T, Kameoka S, Kanemitsu Y, Maeda K, Murata A. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis. J Gastroenterol. 2014;49:646-654. [PMID: 23793379 DOI: 10.1007/s00535-013-0820-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
195 Shen P, Thomas CR, Fenstermaker J, Aklilu M, McCoy TP, Levine EA. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer. J Gastrointest Cancer 2014;45:268-75. [PMID: 24452995 DOI: 10.1007/s12029-014-9578-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
196 van Oosten M, Crane LM, Bart J, van Leeuwen FW, van Dam GM. Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol. 2011;4:71-82. [PMID: 21461170 DOI: 10.1593/tlo.10220] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
197 Kulu Y, Dorfman JD, Kuruppu D, Fuchs BC, Goodwin JM, Fujii T, Kuroda T, Lanuti M, Tanabe KK. Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Ther 2009;16:291-7. [PMID: 18989355 DOI: 10.1038/cgt.2008.83] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
198 Neuwirth MG, Alexander HR, Karakousis GC. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. J Gastrointest Oncol. 2016;7:18-28. [PMID: 26941981 DOI: 10.3978/j.issn.2078-6891.2015.106] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
199 Sugarbaker PH. Peritoneal Metastases from Gastrointestinal Cancer. Curr Oncol Rep. 2018;20:62. [PMID: 29884974 DOI: 10.1007/s11912-018-0703-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
200 Rau B, Brandl A, Pascher A, Raue W, Sugarbaker P. Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer. Visc Med 2017;33:42-6. [PMID: 28612016 DOI: 10.1159/000454694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
201 Lungoci C, Mironiuc AI, Muntean V, Oniu T, Leebmann H, Mayr M, Piso P. Multimodality treatment strategies have changed prognosis of peritoneal metastases. World J Gastrointest Oncol 2016; 8(1): 67-82 [PMID: 26798438 DOI: 10.4251/wjgo.v8.i1.67] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
202 Chan DL, Morris DL, Rao A, Chua TC. Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. Cancer Manag Res 2012;4:413-22. [PMID: 23226073 DOI: 10.2147/CMAR.S31070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
203 Sugarbaker PH. Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? Gastroenterol Res Pract. 2012;2012:309417. [PMID: 22888335 DOI: 10.1155/2012/309417] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
204 Kerscher AG, Mallalieu J, Pitroff A, Kerscher F, Esquivel J. Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital. World J Surg. 2010;34:62-69. [PMID: 20020294 DOI: 10.1007/s00268-009-0281-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
205 Maggiori L, Panis Y. The Authors Reply. Dis Colon Rectum 2015;58:e458-9. [PMID: 26544828 DOI: 10.1097/DCR.0000000000000485] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Guerrero WL, Munene G, Dickson PV, Darby D, Davidoff AM, Martin MG, Glazer ES, Shibata D, Deneve JL. Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy. J Gastrointest Oncol 2018;9:338-47. [PMID: 29755773 DOI: 10.21037/jgo.2018.01.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
207 Adachi T, Hinoi T, Egi H, Shimomura M, Ohdan H. Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery. Surg Today. 2015;45:986-992. [PMID: 25156007 DOI: 10.1007/s00595-014-1017-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
208 Nadler A, McCart JA, Govindarajan A. Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy. Clin Colon Rectal Surg 2015;28:234-46. [PMID: 26648794 DOI: 10.1055/s-0035-1564431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
209 Verheij FS, Bakkers C, van Eden WJ, Aalbers AGJ, Nienhuijs SW, Jóźwiak K, de Hingh IHJT, Kok NFM. Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer. BJS Open 2020. [PMID: 32573969 DOI: 10.1002/bjs5.50313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Cashin PH, Mahteme H, Graf W, Karlsson H, Larsson R, Nygren P. Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer. BMC Cancer 2013;13:435. [PMID: 24063788 DOI: 10.1186/1471-2407-13-435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
211 Kitayama J, Ishigami H, Yamaguchi H, Yamada J, Soma D, Miyato H, Kamei T, Lefor AK, Sata N. Optimal drug delivery for intraperitoneal paclitaxel (PTX) in murine model. Pleura Peritoneum 2017;2:95-102. [PMID: 30911637 DOI: 10.1515/pp-2017-0002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
212 Zhou S, Feng Q, Zhang J, Zhou H, Jiang Z, Liu Z, Zheng Z, Chen H, Wang Z, Liang J, Pei W, Liu Q, Zhou Z, Wang X. High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy. BMC Cancer 2021;21:41. [PMID: 33413223 DOI: 10.1186/s12885-020-07756-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
213 Cotte E, Passot G, Gilly FN, Glehen O. Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2010; 2(1): 31-35 [PMID: 21160814 DOI: 10.4251/wjgo.v2.i1.31] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
214 Bijelic L, Ramos I, Goeré D. The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases. Ann Surg Oncol 2021;28:4140-50. [PMID: 33969466 DOI: 10.1245/s10434-021-10049-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Park EJ, Baik SH, Hur H, Min BS, Kang J, Han YD, Cho MS, Lee KY, Kim NK. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea. Medicine (Baltimore) 2017;96:e6632. [PMID: 28538365 DOI: 10.1097/MD.0000000000006632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Knutsen A, Sielaff TD, Greeno E, Tuttle TM. Staged laparoscopic infusion of hyperthermic intraperitoneal chemotherapy after cytoreductive surgery. J Gastrointest Surg 2006;10:1038-43. [PMID: 16843875 DOI: 10.1016/j.gassur.2006.01.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
217 Kuijpers AM, Mirck B, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, van Ramshorst B, van Ginkel RJ, Havenga K, Bremers AJ. Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol. 2013;20:4224-4230. [PMID: 23897008 DOI: 10.1245/s10434-013-3145-9] [Cited by in Crossref: 138] [Cited by in F6Publishing: 126] [Article Influence: 15.3] [Reference Citation Analysis]
218 Yonemura Y, Canbay E, Ishibashi H. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. ScientificWorldJournal. 2013;2013:978394. [PMID: 23710154 DOI: 10.1155/2013/978394] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
219 Monneuse O, Mestrallet JP, Quash G, Gilly FN, Glehen O. Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model. J Gastrointest Surg 2005;9:769-74. [PMID: 15985231 DOI: 10.1016/j.gassur.2005.02.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
220 Seshadri RA, Glehen O. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 2016; 22(3): 1114-1130 [PMID: 26811651 DOI: 10.3748/wjg.v22.i3.1114] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
221 Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 2012; 4(4): 87-95 [PMID: 22590662 DOI: 10.4240/wjgs.v4.i4.87] [Cited by in CrossRef: 133] [Cited by in F6Publishing: 107] [Article Influence: 13.3] [Reference Citation Analysis]
222 Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL. Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases. Ann Surg Oncol 2019;26:1445-53. [PMID: 30825033 DOI: 10.1245/s10434-019-07218-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
223 Faviana P, Boldrini L, Musco B, Ferrari M, Greco A, Fornaro L, Masi G, Forfori F, Ricci S, Brogi A, Basolo F, Falcone A, Gadducci A, Lippolis PV. Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center. In Vivo 2020;34:2061-6. [PMID: 32606183 DOI: 10.21873/invivo.12008] [Reference Citation Analysis]
224 Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, Ramalingam L, Kandiah C, Chouliaras K, Shen P, Levine EA. PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries. Ann Surg Oncol 2018;25:674-8. [PMID: 29288288 DOI: 10.1245/s10434-017-6315-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
225 Yu HH, Yonemura Y, Hsieh MC, Lu CY, Wu SY, Shan YS. Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination. Ther Clin Risk Manag 2019;15:129-36. [PMID: 30679911 DOI: 10.2147/TCRM.S190641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
226 Boegel KH, Gaertner W, Sharma S, Sanghvi T, Spilseth B. Spectrum of Early Postoperative Multidetector Computed Tomography Findings Following Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. J Comput Assist Tomogr 2020;44:124-30. [PMID: 31939893 DOI: 10.1097/RCT.0000000000000950] [Reference Citation Analysis]
227 Kishimoto H, Zhao M, Hayashi K, Urata Y, Tanaka N, Fujiwara T, Penman S, Hoffman RM. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci U S A 2009;106:14514-7. [PMID: 19706537 DOI: 10.1073/pnas.0906388106] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 8.6] [Reference Citation Analysis]
228 Aoyagi T, Terracina KP, Raza A, Takabe K. Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol 2014; 20(35): 12493-12500 [PMID: 25253949 DOI: 10.3748/wjg.v20.i35.12493] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
229 Chua TC, Chong CH, Liauw W, Morris DL. Approach to rectal cancer surgery. Int J Surg Oncol 2012;2012:247107. [PMID: 22792451 DOI: 10.1155/2012/247107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
230 Coccolini F, Fugazzola P, Montori G, Ansaloni L, Chiarugi M. Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience. J Gastrointest Oncol 2021;12:S144-81. [PMID: 33968435 DOI: 10.21037/jgo-2020-06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Si-Mohamed S, Thivolet A, Bonnot PE, Bar-Ness D, Képénékian V, Cormode DP, Douek P, Rousset P. Improved Peritoneal Cavity and Abdominal Organ Imaging Using a Biphasic Contrast Agent Protocol and Spectral Photon Counting Computed Tomography K-Edge Imaging. Invest Radiol 2018;53:629-39. [PMID: 29794948 DOI: 10.1097/RLI.0000000000000483] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
232 Heaney RM, Shields C, Mulsow J. Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases. World J Gastrointest Oncol 2015; 7(12): 445-454 [PMID: 26688707 DOI: 10.4251/wjgo.v7.i12.445] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
233 Sugarbaker PH. Colorectal cancer: Prevention and management of metastatic disease. Biomed Res Int. 2014;2014:782890. [PMID: 24783222 DOI: 10.1155/2014/782890] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
234 Mo S, Cai G. Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature. Gastroenterol Res Pract. 2016;2016:1516259. [PMID: 28105045 DOI: 10.1155/2016/1516259] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
235 Adileh M, Yuval JB, Walch HS, Chatila WK, Yaeger R, Garcia-Aguilar J, Schultz N, Paty PB, Cercek A, Nash GM. Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin. Ann Surg Oncol 2021;28:1109-17. [PMID: 32844293 DOI: 10.1245/s10434-020-08993-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, Yun SH, Kim JG, Kang BW. Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center. Surg Endosc. 2014;28:1555-1562. [PMID: 24368743 DOI: 10.1007/s00464-013-3351-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
237 Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Otani K, Kishimoto I, Shintani Y, Inoue M, Kimura T, Sawabata N, Minami M, Nakagiri T, Funaki S, Takeuchi Y, Maeda H, Kidoya H, Kiyonari H, Shioi G, Arai Y, Hasegawa T, Takakura N, Hori M, Ohno Y, Miyazato M, Mochizuki N, Okumura M, Kangawa K. Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells. Proc Natl Acad Sci U S A 2015;112:4086-91. [PMID: 25775533 DOI: 10.1073/pnas.1417273112] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
238 Van der Speeten K, Lemoine L, Sugarbaker P. Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura Peritoneum 2017;2:63-72. [PMID: 30911634 DOI: 10.1515/pp-2017-0003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
239 Facy O, Pages PB, Ortega-Deballon P, Magnin G, Ladoire S, Royer B, Chauffert B, Bernard A. High-pressure intrapleural chemotherapy: feasibility in the pig model. World J Surg Oncol 2012;10:29. [PMID: 22309737 DOI: 10.1186/1477-7819-10-29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
240 Saxena A, Yan TD, Morris DL. A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World J Surg. 2010;34:70-78. [PMID: 19760317 DOI: 10.1007/s00268-009-0206-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
241 Assaf D, Mor E, Laks S, Zohar N, Benvenisti H, Hazzan D, Segev L, Akopyan OK, Shacham-Shmueli E, Margalit O, Halpern N, Boursi B, Ben-Yaacov A, Nissan A, Adileh M. The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Eur J Surg Oncol 2021:S0748-7983(21)00695-8. [PMID: 34489120 DOI: 10.1016/j.ejso.2021.08.023] [Reference Citation Analysis]
242 Yuan Y, Yao S, Luo GH, Zhang XY. Impact of metabolism-related mutations on the heart rate of gastric cancer patients after peritoneal lavage. World J Clin Cases 2021; 9(6): 1318-1328 [PMID: 33644198 DOI: 10.12998/wjcc.v9.i6.1318] [Reference Citation Analysis]
243 Soucisse ML, Liauw W, Hicks G, Morris DL. Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis. Pleura Peritoneum 2019;4:20190007. [PMID: 31667329 DOI: 10.1515/pp-2019-0007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
244 Schaap DP, de Valk KS, Deken MM, Meijer RPJ, Burggraaf J, Vahrmeijer AL, Kusters M; SGM-101 study group. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.Br J Surg. 2020;107:334-337. [PMID: 31960953 DOI: 10.1002/bjs.11523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
245 Kitai T, Yamanaka K, Miyauchi Y, Kawashima M. Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy. Int J Clin Oncol 2017;22:519-25. [PMID: 28054141 DOI: 10.1007/s10147-016-1078-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
246 Vaira M, Robella M, Massucco P, De Simone M. Considerations on the Selection Process for Cytoreductive Surgery and Hyperthermic IntraPeritoneal Chemotherapy for Colorectal Carcinomatosis. Ann Surg 2015;262:e48. [PMID: 25405554 DOI: 10.1097/SLA.0000000000001021] [Reference Citation Analysis]
247 Coco D, Leanza S. Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer. Maedica (Bucur) 2019;14:280-6. [PMID: 31798746 DOI: 10.26574/maedica.2019.14.3.280] [Reference Citation Analysis]
248 Yan TD. Peritoneal carcinomatosis of colorectal origin: standard of care. Ann Surg. 2006;244:632-63; author reply 632-63;. [PMID: 16998376 DOI: 10.1097/01.sla.0000239629.96036.cd] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
249 Downs-Canner S, Shuai Y, Ramalingam L, Pingpank JF, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases. J Surg Res 2017;219:194-201. [PMID: 29078882 DOI: 10.1016/j.jss.2017.05.126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
250 Adusumilli PS, Eisenberg DP, Chun YS, Ryu KW, Ben-Porat L, Hendershott KJ, Chan MK, Huq R, Riedl CC, Fong Y. Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery. J Gastrointest Surg 2005;9:1138-46; discussion 1146-7. [PMID: 16269385 DOI: 10.1016/j.gassur.2005.06.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
251 Kulu Y, Müller-Stich B, Büchler MW, Ulrich A. Surgical treatment of peritoneal carcinomatosis: current treatment modalities. Langenbecks Arch Surg 2014;399:41-53. [PMID: 24249036 DOI: 10.1007/s00423-013-1144-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
252 Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263-267. [PMID: 22162570 DOI: 10.1200/jco.2011.37.1039] [Cited by in Crossref: 333] [Cited by in F6Publishing: 132] [Article Influence: 30.3] [Reference Citation Analysis]
253 Buk OF, Ocak S, Genc B, Avcı B, Uzuner HO. Is platelet-rich plasma improves the anastomotic healing in hyperthermic intraperitoneal chemotherapy with oxaliplatin: an experimental rat study. Ann Surg Treat Res 2020;98:89-95. [PMID: 32051817 DOI: 10.4174/astr.2020.98.2.89] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
254 März L, Piso P. Treatment of peritoneal metastases from colorectal cancer. Gastroenterol Rep (Oxf) 2015;3:298-302. [PMID: 26424828 DOI: 10.1093/gastro/gov044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
255 Vallicelli C, Cavaliere D, Catena F, Coccolini F, Ansaloni L, Poiasina E, Abongwa HK, De Simone B, Alberici L, Framarini M, Verdecchia GM. Management of peritoneal carcinomatosis from colorectal cancer: review of the literature. Int J Colorectal Dis 2014;29:895-8. [PMID: 24915844 DOI: 10.1007/s00384-014-1907-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
256 Ashvin R, Nikhilesh J. Preoperative Preparation and Patient Selection for Cytoreductive Surgery and HIPEC. Indian J Surg Oncol 2016;7:208-14. [PMID: 27065711 DOI: 10.1007/s13193-016-0514-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
257 Kim YJ, Kim CH. Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer. Ann Coloproctol 2021;37:425-33. [PMID: 34961304 DOI: 10.3393/ac.2021.00920.0131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Seshadri RA, Glehen O. The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Indian J Surg Oncol 2016;7:198-207. [PMID: 27065710 DOI: 10.1007/s13193-016-0502-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
259 Sugarbaker PH. Peritoneal Metastases: Prevention and Treatment. Indian J Surg Oncol 2016;7:137-8. [PMID: 27065703 DOI: 10.1007/s13193-016-0493-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
260 Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5. [PMID: 19133112 DOI: 10.1186/1477-7819-7-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 87] [Article Influence: 8.5] [Reference Citation Analysis]
261 Ceelen WP, Flessner MF. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol 2010;7:108-15. [DOI: 10.1038/nrclinonc.2009.217] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 8.2] [Reference Citation Analysis]
262 Arias F, Otero JM, Londoño E, Becerra H, Carvajalino S, Rodríguez CI, Granados JJ, Quintero P, Mora M, Castro C, Carranza H, Vargas C, Reyes A, Rojas L, Reveiz L, Cardona AF. [Morbidity and mortality in a series of patients suffering from intraperitoneal neoplasia treated with peritoneal cytoreduction and hyperthermic intraperitoneal chemotherapy at the Fundación Santa Fe de Bogotá Teaching Hospital (ONCOLGroup--ATIA study)]. Rev Gastroenterol Mex 2012;77:66-75. [PMID: 22672853 DOI: 10.1016/j.rgmx.2012.03.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Nair RL, Tobias J, Stemmerman G, Lowy AM. Cerebral edema in a patient following cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemoperfusion. World J Surg Oncol 2006;4:85. [PMID: 17137499 DOI: 10.1186/1477-7819-4-85] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
264 Simkens GA, Wintjens AGWE, Rovers KP, Nienhuijs SW, de Hingh IH. Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC. Cancer Manag Res 2021;13:5239-49. [PMID: 34234566 DOI: 10.2147/CMAR.S277912] [Reference Citation Analysis]
265 Mor E, Assaf D, Laks S, Benvenisti H, Schtrechman G, Hazzan D, Segev L, Yaka R, Shacham-Shmueli E, Margalit O, Halpern N, Perelson D, Kaufmann MI, Ben-Yaacov A, Nissan A, Adileh M. Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with Survival. Ann Surg Oncol 2021. [PMID: 34232423 DOI: 10.1245/s10434-021-10367-6] [Reference Citation Analysis]
266 Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga KK. Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 2014;12:270. [PMID: 25145962 DOI: 10.1186/1477-7819-12-270] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
267 Jafari MD, Carmichael JC, Dayyani F, McKinney C, Wenzel L, Zell JA, Pigazzi A. Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol. Clin Colorectal Cancer 2021:S1533-0028(21)00124-9. [PMID: 34980534 DOI: 10.1016/j.clcc.2021.11.004] [Reference Citation Analysis]
268 Terzi C, Arslan NC, Canda AE. Peritoneal carcinomatosis of gastrointestinal tumors: Where are we now? World J Gastroenterol 2014; 20(39): 14371-14380 [PMID: 25339824 DOI: 10.3748/wjg.v20.i39.14371] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
269 Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res 2017;9:259-66. [PMID: 28721098 DOI: 10.2147/CMAR.S119569] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
270 Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK. Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol 2020;27:134-46. [PMID: 31243668 DOI: 10.1245/s10434-019-07526-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
271 Kamada Y, Hida K, Yonemura Y, Sugarbaker PH, Ghabra S, Ishihara S, Nagata H, Murono K, Goi T, Katayama K, Morikawa M, Rau B, Piso P, Acs M, Coccolini F, Canbay E, Hsieh MC, Bhatt A, Bonnot PE, Glehen O. The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI. Cancers (Basel) 2021;13:2964. [PMID: 34199234 DOI: 10.3390/cancers13122964] [Reference Citation Analysis]
272 Arjona-Sánchez A, Medina-Fernández FJ, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S. Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview. World J Gastrointest Oncol 2014; 6(10): 407-412 [PMID: 25320657 DOI: 10.4251/wjgo.v6.i10.407] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
273 Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, Ichinose M, Miura M, Li Y. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol. 2010;2:85-97. [PMID: 21160926 DOI: 10.4251/wjgo.v2.i2. 85] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Yan TD, Cao CQ, Munkholm-Larsen S. A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy. World J Gastrointest Oncol 2010; 2(2): 109-116 [PMID: 21160929 DOI: 10.4251/wjgo.v2.i2.109] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
275 Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218:573-585. [PMID: 24491244 DOI: 10.1016/j.jamcollsurg.2013.12.013] [Cited by in Crossref: 150] [Cited by in F6Publishing: 138] [Article Influence: 16.7] [Reference Citation Analysis]
276 Narasimhan V, Warrier S, Michael M, McCormick J, Ramsay R, Lynch C, Heriot A. Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons. Pleura Peritoneum 2019;4:20190022. [PMID: 31799373 DOI: 10.1515/pp-2019-0022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215:412-417. [PMID: 22634117 DOI: 10.1016/j.jamcollsurg.2012.04.023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
278 Bong TSH, Tan GHC, Chia C, Soo KC, Teo MCC. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin Oncol. 2017;22:511-518. [PMID: 28138878 DOI: 10.1007/s10147-017-1092-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
279 Dervenis C, Xynos E, Sotiropoulos G, Gouvas N, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Kountourakis P, Kyriazanos I, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Ziras N, Souglakos J. Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol 2016;29:390-416. [PMID: 27708505 DOI: 10.20524/aog.2016.0050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
280 Wu W, Yan S, Liao X, Xiao H, Fu Z, Chen L, Mou J, Yu H, Zhao L, Liu X. Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and meta-analysis. Oncotarget 2017;8:113202-12. [PMID: 29348899 DOI: 10.18632/oncotarget.21912] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
281 Sugarbaker PH, Chang D. Revised prognostic indicators for treatment of lymph node positive colorectal peritoneal metastases. J Surg Oncol 2022. [PMID: 35032331 DOI: 10.1002/jso.26792] [Reference Citation Analysis]
282 Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, Ichinose M, Miura M, Li Y. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol. 2010;2:85-97. [PMID: 21160926 DOI: 10.4251/wjgo.v2.i2. 85] [Reference Citation Analysis]
283 Anghelescu DL, Brown CL, Murphy AJ, Davidoff AM, Dickson PV, Glazer ES, Stiles ZE, Bishop MW, Douthitt L, Deneve JL. Anesthesia and Pain Management for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors in Children, Adolescents, and Young Adults. Ann Surg Oncol 2019;26:131-8. [PMID: 30353396 DOI: 10.1245/s10434-018-6808-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]